These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1822999)

  • 1. Parathyroid hormone secretory reserve in patients submitted to 131-iodine therapy for hyperthyroidism.
    Vieira JG; Brandão CM; Kasamatsu TS; Furlanetto RP
    Braz J Med Biol Res; 1991; 24(11):1103-5. PubMed ID: 1822999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hyperparathyroidism after radioactive iodine therapy for Graves' disease: a case report].
    Kawamura J; Tobisu K; Sanada S; Okada Y; Yoshida O; Minami S; Hino M; Shigeno T; Konishi J; Morita R
    Hinyokika Kiyo; 1983 Nov; 29(11):1513-9. PubMed ID: 6689566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Parathyroid function in hyperthyroidism: implications for bone metabolism and effect of the treatment].
    Furlanetto RP; Castro ML; de Mesquita CH; Kasamatsu TS; Vieira JG
    Rev Paul Med; 1991; 109(2):55-60. PubMed ID: 1909454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant Graves' disease and primary hyperparathyroidism. Influence of hyperthyroidism on serum calcium and parathyroid hormone.
    Arem R; Lim-Abrahan MA; Mallette LE
    Am J Med; 1986 Apr; 80(4):693-8. PubMed ID: 3754385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-year follow-up of Graves' disease treatment by four different protocols of radioiodine administration.
    Calegaro JU; De Freitas Gomes E; Bae SH; Ulyssea R; Casulari LA
    Panminerva Med; 2000 Dec; 42(4):241-5. PubMed ID: 11294085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
    Franklyn JA; Daykin J; Holder R; Sheppard MC
    QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioiodine treatment of hyperthyroidism-prognostic factors for outcome.
    Allahabadia A; Daykin J; Sheppard MC; Gough SC; Franklyn JA
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3611-7. PubMed ID: 11502786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of methimazole pretreatment on serum thyroid hormone levels after radioactive treatment in Graves' hyperthyroidism.
    Andrade VA; Gross JL; Maia AL
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4012-6. PubMed ID: 10566642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
    Bakker SC; Zanin DE; Zweers EJ
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reciprocal changes in parathyroid hormone and thyroid function after radioiodine treatment of hyperthyroidism.
    Ross DS; Nussbaum SR
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1216-9. PubMed ID: 2723030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left-shifted relation between calcium and parathyroid hormone in Graves' disease.
    Annerbo M; Hultin H; Stålberg P; Hellman P
    J Clin Endocrinol Metab; 2014 Feb; 99(2):545-51. PubMed ID: 24248181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyrotropin receptor antibodies and Graves' disease, a side-effect of 131I treatment in patients with nontoxic goiter.
    Nygaard B; Knudsen JH; Hegedüs L; Scient AV; Hansen JE
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2926-30. PubMed ID: 9284721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperparathyroidism after radioactive iodine therapy for Graves disease.
    Esselstyn CB; Schumacher OP; Eversman J; Sheeler L; Levy WJ
    Surgery; 1982 Nov; 92(5):811-3. PubMed ID: 6897129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease.
    Alexander EK; Larsen PR
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1073-7. PubMed ID: 11889166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of adjunctive potassium iodide after radioactive iodine (131I) treatment of Graves' hyperthyroidism.
    Ross DS; Daniels GH; De Stefano P; Maloof F; Ridgway EC
    J Clin Endocrinol Metab; 1983 Aug; 57(2):250-3. PubMed ID: 6688081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of parathyroid hormone and vitamin D in essential hypertension.
    Young EW; Morris CD; Holcomb S; McMillan G; McCarron DA
    Am J Hypertens; 1995 Oct; 8(10 Pt 1):957-64. PubMed ID: 8845076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen replacement decreases the set point of parathyroid hormone stimulation by calcium in normal postmenopausal women.
    Boucher A; D'Amour P; Hamel L; Fugère P; Gascon-Barré M; Lepage R; Ste-Marie LG
    J Clin Endocrinol Metab; 1989 Apr; 68(4):831-6. PubMed ID: 2921312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypocalcemia following treatment with radioiodine in a child with Graves' disease.
    Komarovskiy K; Raghavan S
    Thyroid; 2012 Feb; 22(2):218-22. PubMed ID: 22176499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent hyperthyroidism and hyperparathyroidism: influence of hyperthyroidism on serum magnesium, free calcium and parathyroid hormone.
    Lam HC; Ho LT; Tang KT; Ching KN
    Taiwan Yi Xue Hui Za Zhi; 1989 Jun; 88(6):601-5. PubMed ID: 2794961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease.
    Chen JJ; Ladenson PW
    J Clin Endocrinol Metab; 1986 Jul; 63(1):102-6. PubMed ID: 2423547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.